ABSTRACT OBJECTIVES: To estimate the public health impacts of changes in fine particle air pollution in Canada between 2000 and 2011, employing nationally comprehensive exposure estimates and quantifying the impacts on life expectancy, mortality and morbidity.
T
here is a large body of literature linking air pollution exposure with morbidity and mortality.
1,2 A number of estimates have been generated of the public health impacts of air pollution exposure in Canada 3,4 and worldwide. 5 Previous studies have generally involved static estimates comparing current or status quo concentrations with zero, background or counterfactual (a theoretical minimum based on the lowest level at which effects have been observed in epidemiological studies) concentrations. Estimates have also been produced of the projected health impacts of modelled changes in air pollution concentrations resulting from specific proposed policies or programs, using tools such as the United States Environmental Protection Agency's (USEPA) Environmental Benefits Mapping and Analysis Program (BenMAP) 6 or Health Canada's Air Quality Benefits Assessment Tool. 7 While these are informative in positioning air pollution as a public health priority and in weighing the costs and benefits of proposed policies, the background, counterfactual and projected concentrations are nonetheless hypothetical targets. In contrast, examination of the public health impacts of observed temporal changes in pollutant concentrations can be potentially informative with respect to both evaluating the effectiveness of past policies and programs to control emissions, as well as identifying priorities for new control strategies.
Until recently, air pollution exposure estimates in these studies have generally been restricted to areas where ground-based monitoring data are available. A substantial improvement in exposure assignment was realized in the 2010 Global Burden of Disease study, which employed globally comprehensive exposure estimates derived from monitoring data, chemical/ meteorological air quality models and remote sensing. 5 A variety of metrics have been employed to quantify impacts in previous studies, including number of deaths or morbidity outcomes, [3] [4] [5] life expectancy, 8 disability-adjusted life years (DALYs), 5 quality-adjusted life years (QALYs) 9 and monetary valuation. 3 Particularly with respect to mortality outcomes, there has been considerable debate as to which is the most meaningful metric that most accurately characterizes the true impact of air pollution on health. [10] [11] [12] Life expectancy has the advantage of capturing the effects of premature mortality on life span in a manner that is arguably more readily understood by a lay audience than QALYs and DALYs. In this paper, we estimate the effects of actual observed changes in air pollution concentrations over an 11-year period, employ spatially comprehensive exposure estimates derived from satellite remote sensing and quantify the impacts on life expectancy, mortality and morbidity.
METHODS

Exposure assignment
Estimates of particulate matter of median aerodynamic diameter <2.5 μm (PM 2.5 ) were based on satellite remote sensing observations for the periods 1999-2001 and 2010-2012. 13 Decadal mean satellite-derived PM 2.5 concentrations were well correlated (R = 0.76, slope = 0.96) with data from ground-based monitoring across North America. Air pollution exposure surface grid cells were mapped to population by area weighting based on 478,780 dissemination blocks, and these were further weighted up to census divisions (n = 288) using population weighting by dissemination area. With respect to short-term exposures, changes in annual average exposure were assumed to equal the average change in daily exposure. While the focus of this analysis is on the impacts of observed changes in PM 2.5 between 2000 and 2011, we also estimated the impacts of further reductions of PM 2.5 from 2011 levels to an estimated natural background concentration of 1.8 μg/m 3 , which is based on a review of monitoring data from rural and remote monitoring sites during time periods classified as being influenced primarily by background air mass types. 4 This concentration is comparable in concept to the USEPA "policyrelevant background", defined as concentrations that would occur in the absence of anthropogenic emissions in continental North America. 14 It is also similar to the lowest concentrations observed in our data and to background concentrations employed in a recent US analysis, which ranged from 0.74 to 1.72 μg/m 3 by region. 15 
Estimation of health impacts
Change in frequency of health outcomes was estimated for 2011 as the product of the 2011 population, annual baseline rate of the health outcome and the proportional change in health outcome per specified change in PM 2.5 concentration. Counts of mortality and hospital admissions were obtained for each census division (CD) with the exception of Quebec, where these data were not available. Quebec mortality counts for each CD were derived by applying national age-and cause-specific rates to the population age distribution of individual CDs. For Quebec hospital admission counts, we employed age-and cause-specific provincial rates for Quebec, applied to the population age distribution of individual CDs. Rates were averaged over the three most recent years of available data to improve stability. Baseline rates of other health outcomes were applied uniformly to all CDs. Proportional change in health outcome was derived from linear, log relative risk or log odds ratio models as follows:
where π lin , π lrr and π lor are the proportional change and β lin , β lrr and β lor are the literature-derived regression coefficients corresponding to linear, log relative risk and log odds ratio models respectively; μ is the mean baseline rate of the given outcome from the same source in the literature as β lin; and Δx is the change in PM 2.5 concentration.
Analyses of mortality and life expectancy employed causespecific β values for mortality from ischemic heart disease, cerebrovascular disease, lung cancer and chronic obstructive pulmonary disease (COPD) for adults 25 years and over, in keeping with the approach employed in the Global Burden of Disease analysis. 5 These were derived from a meta-analysis of worldwide cohort studies. 16 As a sensitivity analysis, we also employed results for all internal cause mortality from a Canadian cohort study, 17 which was excluded from the metaanalysis because it lacked data on personal risk factors such as smoking. β values for other outcomes were based on individual studies. Values of π lin , π lrr and π lor and their sources, as well as corresponding baseline rates of health outcomes and their sources, are summarized in Supplementary Table 1 .
Methods for estimating changes in life expectancy have been described in detail elsewhere. 18 Briefly, we estimated changes in life expectancy in relation to PM 2.5 using standard life table methods such that, at each age group, cause-and age-specific mortality rates were modified by the proportional change in mortality associated with a specified change in PM 2.5 . Changes in the probability of surviving to the next age group were propagated through the life table in order to estimate the change in life expectancy. We employed the 2009-2011 life table for Canada. As a sensitivity analysis, we used provincial life tables for Ontario, Manitoba, Saskatchewan, Alberta and British Columbia. Because we analyzed life expectancy impacts in relation to the excess risk from air pollution on COPD, cerebrovascular disease, ischemic heart disease and lung cancer mortality, we required mortality rates for these conditions by five-year age group to apply to the life table. These data were not available for Quebec, and province-specific counts by cause and five-year age group for smaller provinces were considered too small and likely to produce unstable rates.
Uncertainty
The analysis was conducted using the Air Quality Benefits Assessment Tool 7 in Microsoft Excel and the @Risk add-in. Monte
Carlo simulations employing 10,000 iterations were used to propagate uncertainty in exposure response functions according to the input distributions shown in Supplementary The estimated health impacts of these changes are summarized in Table 1 . An increase in life expectancy of 0.10 years (95% CI 0.03-0.23) was estimated, representing a 0.12% increase. The percentage change in other outcomes ranged from 0.13% for cardiac emergency room visits and hospital admissions to 3.55% for mortality. CDs with the greatest reductions in PM 2.5 and corresponding increases in life expectancy and those with the greatest increases in PM 2.5 and reductions in life expectancy are shown in Table 2 
DISCUSSION
We estimated the impacts of changes in PM 2.5 concentrations in Canada between 2000 and 2011 using nationally comprehensive These changes were estimated to result in a national population weighted average increase in life expectancy of 0.10 years (up to approximately 1/3 of a year in the areas experiencing the greatest reductions in concentrations) and reductions in the frequency of mortality and morbidity of up to 3.6%. We also estimated that further reductions in PM 2.5 from 2011 concentrations to an estimated natural background level would result in an additional improvement in life expectancy of 0.27 years (up to 0.69 years in individual CDs) and a reduction in mortality of 5,600 or 8.1%. The overall downward trend in PM 2.5 concentrations is consistent with trends in emissions of PM 2.5 precursors in both Canada and the US. 19, 20 These may be attributable to numerous policy initiatives in both countries, including reduced sulphur content in fuels and controls on coal-fired power plant emissions, and to reduced economic activity after 2008.
21,22
Indeed, we found that the majority of the reduction in population weighted average PM 2.5 concentration across Canada occurred after 2006. It has also been suggested that localized upward trends in some western areas may be due to increased oil and gas development and wildfire activity. 21 In a recent analysis based on regression of county-specific change in life expectancy and decreased PM 2.5 of attributable DALYs. 5 7,200 attributable deaths were estimated for Canada, 28 which is higher than our estimate. However, this was based on a higher counterfactual exposure level and generally higher estimated PM 2.5 concentrations. In addition, PM 2.5 concentrations were randomly assigned to grid cells with modelled concentrations less than 10 μg/m 3 (which would include most of Canada), because the air pollution estimation model performed poorly relative to measured values at low concentrations. 29 This would tend to obscure findings in these areas. We also found that, not surprisingly, estimates of life expectancy and mortality impacts were substantially larger when based on an analysis of all internal causes of death rather than four selected causes, as employed in the Global Burden of Disease initiative. The latter approach was adopted because of potentially wide variation in underlying cause-specific mortality rates throughout the world, which could threaten the validity of estimating impacts based simply on all-cause mortality. While this approach facilitates international comparisons, it clearly represents a conservative estimate of impacts on mortality and life expectancy. Health Canada has estimated that 4,200 deaths (5.7%) were attributable to long-term exposure to PM 2.5 in the eight largest Canadian cities where air pollution monitoring data were available (representing about 30% of the Canadian population). . The Canadian Medical Association extrapolated monitoring data to all of Canada, estimating that 21,000 deaths could be attributed to PM 2.5 based on a change in exposure from 2008 levels to zero concentration. 3 Extrapolation from monitored to unmonitored areas is likely to overestimate concentrations in those areas, thus biasing impact estimates upwards. There are varied opinions in the literature on the most appropriate metric to capture the public health impacts of air pollution. Attributable deaths in particular have been criticized because they do not account for the extent to which life is shortened, especially when based only on effects in studies of short-term exposure. [10] [11] [12] Life expectancy has been advanced as an alternative metric from the point of view of accounting for both risk and change in life span. [10] [11] [12] Disability-adjusted life expectancy and quality-adjusted life expectancy additionally account for change in health status and in principle can capture the effects of air pollution on morbidity. However, acute morbidity, including outcomes such as disease exacerbations resulting in emergency visits or hospital admissions, are not readily captured by these metrics because of their relatively short duration (days to weeks vs. years). In addition, DALYs and QALYs, while informative for decision scientists, are not intuitive for non-experts.
Strengths and limitations
The strengths of our study include estimation of the impacts of actual observed changes in air pollution concentrations over an 11-year period, use of spatially comprehensive exposure estimates derived from satellite remote sensing and quantification of impacts using life expectancy, as well as mortality and morbidity.
The limitations include uncertainty about whether the slope of concentration response functions we employed, which in some cases were based primarily on studies from the US or elsewhere at generally higher PM 2.5 concentrations, are applicable at the lower concentrations observed in Canada. However, a recent Canadian cohort study found that the magnitude of the risk was similar to that observed elsewhere, despite lower average PM 2.5 concentrations. 17 We also assumed that concentration-response functions were static over time. While several studies have attempted to discern trends in risk over time, the results have so far been inconsistent. ), pondérée selon la population, a été observée entre 2000 et 2011. On estime que cela a entraîné une hausse moyenne nationale de l'espérance de vie, pondérée selon la population, de 0.10 an (intervalle de confiance de 95 % : 0.03-0.23; jusqu'à 0.34 an dans certains secteurs du recensement) et des baisses de fréquence de la mortalité et de la morbidité jusqu'à 3.6 %. Des augmentations maximales de 3.5 μg/m 3 des MP 2.5 ont été observées dans certains secteurs du recensement, en particulier dans les Prairies.
CONCLUSION : À l'échelle nationale, les changements dans les concentrations en MP 2.5 survenus entre 2000 et 2011 étaient associés à une amélioration estimative de l'espérance de vie moyenne nationale, pondérée selon la population, et à une baisse nette de la mortalité et de la morbidité. Les régions où la situation ne s'est pas améliorée ou s'est aggravée durant la période à l'étude devraient faire l'objet d'un examen approfondi afin de trouver des options pour réduire les concentrations en MP 2.5 .
